The Problem of Water Resources Pollution with Active Pharmaceutical Substances and the Possibility of Its Solving
Environmental pollution by pharmaceutical products has become one of the most significant problems in the modern world. It also touched upon the countries of Central Asia, including Kazakhstan. Pharmaceutical production in the country is growing rapidly, with drugs widely available to the population. This inevitably leads to the fact that a significant part of medicinal compounds gets into the environment and, in particular, into water bodies. It is obvious that pollution of the aquatic environment with various active pharmaceutical compounds harms the aquatic ecosystem, worsens the quality of water, and, subsequently, human health. That is why the need for the inactivation of pharmaceutical products polluting the aquatic environment is so urgent. The objectives of this study were to identify pharmaceutical compounds in the aquatic environment of Kazakhstan and to test the effectiveness of activated carbon as a means for wastewater treatment by adsorption.
 Aubakirova, B., Beisenova, R. and Boxall, A.B.A. 2017. Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan. Human and Ecological Risk Assessment, 13(5): 832-839. DOI:https://doi.org/10.1002/ieam.1895
 Balykbaeva, A.S. 2017. Pollution of Water Resources of Kazakhstan and Methods of Water Purification. Journal Oqu-Zaman, November 11, 2017. Available at: https://oqu-zaman.kz/?p=20455
 Berninger, J.P., Lalone, C.A., Villeneuve, D.L. and Ankley, G.T. 2016. Prioritization of pharmaceuticals for potential environmental hazard through leveraging a large-scale mammalian pharmacological dataset. Environmental Toxicology and Chemistry, 35(4): 1007-1020. DOI: https://doi.org/10.1002/etc.2965
 Besse, J.P., Kausch-Barreto, C. and Garric, J.2008. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: Application to the French situation and preliminary prioritization. Human and Ecological Risk Assessment, 14(4): 665-695. DOI: https://doi.org/10.1080/10807030802235078
 Boxall, A.B.A., Kolpin, D.W., Halling-Sorensen, B. and Tolls, J. 2003. Are veterinary medicines causing environmental risks. Environmental Science & Technology, 37(15): 286-294. DOI:https://doi.org/10.1021/es032519b
 Brausch, J.M. and Rand, G.M. 2011. A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere, 82(11): 1518-1532. DOI:https://doi.org/10.1016/j.chemosphere.2010.11.018
 Brausch, J.M. and Rand, G.M. 2011. A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere, 82(11): 1518-1532.
 Caban, M., Lis, E., Kumirska, J. and Stepnowski, P. 2015. Determination of pharmaceutical residues in drinking water in Poland using a new SPE-GC-MS(SIM) method based on Speedisk extraction disks and DIMETRIS derivatization. Science of the Total Environment, 538: 402-411. DOI:https://doi.org/10.1016/j.scitotenv.2015.08.076
 Cooper, E.R., Siewicki, T.C. and Phillips, K.2008. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. Science of the Total Environment, 398(1-3): 26-33. DOI:https://doi.org/10.1016/j.scitotenv.2008.02.061
 de Araujo Almeida Freitas, L. and Radis-Baptista, G. 2021. Pharmaceutical Pollution and Disposal of Expired, Unused, and Unwanted Medicines in the Brazilian Context. Journal of Xenobiotics, 11(2): 61-76. DOI: https://doi.org/10.3390/jox11020005
 Doerr-MacEwen, N.A. and Haight, M.E. 2006. Expert stakeholders' views on the management of human pharmaceuticals in the environment. Environmental Management, 38(5): 853-866. DOI:https://doi.org/10.1007/s00267-005-0306-z
 Donn, J. 2009. Tons of Released Drugs Taint U.S. Water. Available at: https://www.usnews.com/science/articles/2009/04/19/tons-of-released-drugs-taint-us-water?PageNr=1
 Executive Agency for Health and Consumers. 2013. Study on the environmental risks of medicinal products. Final report. Luxembourg: Executive Agency for Health and Consumers.
 Felicity, T. 2017. Pharmaceutical Waste in the Environment: View from a Cultural Position. Panorama of Public Health, 3(1): 133-139.
 Fernandez, K. and Tarason, S.P. 2014. The impact of pharmaceuticals on the environment. Encyclopedia of Toxicology (third edition). Elsevier: Amsterdam.
 Guo, J.H., Sinclair, C.J., Selby, K. and Boxall, A.B.A. 2016. Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment. Environmental Toxicology and Chemistry, 35(6): 1550-1559. DOI: https://doi.org/10.1002/etc.3319
 Gworek, B., Kijenska, M., Wrzosek, J. and Graniewska, M. 2021. Pharmaceuticals in the Soil and Plant Environment: A Review. Water, Air and Soil Pollution, 232. DOI: https://doi.org/10.1007/s11270-020-04954-8
 Illarionova, E.A., Syrovatsky, I.P., Inozemtsev, P.O. 2011. A new version of the spectrophotometric determination of drotaverine. Siberian Medical Journal, 5: 75-77.
 Jones, O.A.H., Voulvoulis, N. and Lester, J.N. 2003. Potential impact of pharmaceuticals on environmental health. Bulletin of the World Health organization, 10: 768-769.
 Kaliev, A. 2021. Kazakhstan faces water shortage. Available at: https://inbusiness.kz/ru/news/opasnaya-situaciya-s-vodnymi-resursami-kazahstanu-grozit-deficit-vody
 Kim, Y., Jung, J., Kim, M., Park, J., Boxall, A.B.A. and K. Choi. 2008. Prioritizing veterinary pharmaceuticals for aquatic environment in Korea. Environmental Toxicology and Pharmacology, 26(2): 167-176. DOI:https://doi.org/10.1016/j.etap.2008.03.006
 Kummerer, K. 2010. Pharmaceuticals in the environment. Annual review of environment and resources, 35: 57-75. DOI: 10.1146/annurev-environ-052809-161223
 Lykov, I.N. 2020. Pharmaceutical Environmental Pollution. Fundamental medicine, 2: 23-27.
 Massima Mouele, E.S., et al. 2021. Removal of Pharmaceutical Residues from Water and Wastewater Using Dielectric Barrier Discharge Methods—A Review. International Journal of Environmental Research and Public Health, 18: 1683. DOI: https://doi.org/10.3390/ijerph18041683
 Naizabekova, A. 2020. How Coronavirus Affects the Pharmaceutical Market in Kazakhstan. Available at: https://forbes.kz//process/medicine/kak_koronavirus_vliyaet_na_farmatsevticheskiy_ryinok_kazahstana/
 Papagiannaki, D., et al. 2022. From monitoring to treatment, how to improve water quality: The pharmaceuticals case. Chemical Engineering Journal Advances, 10: 100245. DOI:https://doi.org/10.1016/j.ceja.2022.100245
 Roos, V., Gunnarsson, L., Fick, J., Larsson, D.G.J. and Ruden, C.2012. Prioritizing pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection. Science of The Total Environment, 421: 102-110. DOI: https://doi.org/10.1016/j.scitotenv.2012.01.039
 Scheytt, T.J., Mersmann, P. and Heberer, T.2006. Mobility of pharmaceuticals carbamazepine, diclofenac, ibuprofen, and propyphenazone in miscible-displacement experiments. Journal of Contaminant Hydrology, 83: 53–69. DOI: https://doi.org/10.1016/j.jconhyd.2005.11.002
 Shigei, M., Assayed, A., Hazaymeh, A. and Dalahmeh, S.S. 2021. Pharmaceutical and Antibiotic Pollutant Levels in Wastewater and the Waters of the Zarqa River, Jordan. Applied Sciences, 11: 8638. DOI:https://doi.org/10.3390/app11188638
 Tashenov, A. and Cherednichenko, N. 2015. Development Prospects for the Pharmaceutical Market of the Single Economic Space. Available at: http://www.eabr.org/general/upload/docs/AU/%D0%90%D0%A3%20-%20%D0%98%D0%B7%D0%B4%D0%B0%D0%BD%D0%B8%D1%8F%20-%202013/OBZOR_18_rus.pdf
 Zuccato, E., Castiglioni, S. and Fanelli, R. 2005. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. Journal of Hazardous Materials, 122(3): 205-209. DOI:https://doi.org/10.1016/j.jhazmat.2005.03.001
 AQUITAS. 2015. Pharmaceutical Market of Kazakhstan: History, Main Directions of Development and Current State. https://aequitas.kz/
 European Environment Agency. 2010. Pharmaceuticals in the environment: results of an EEA Workshop. Copenhagen: EEA.
 IMS Institute for Healthcare Informatics. 2020. Global Use of Medicines in 2020. Report by the IMS Institute for Healthcare Informatics. Available at: https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/global-medicines-use-in-2020
 OECD. 2002. OECD guidelines for the testing of chemicals Freshwater Alga and Cyanobacteria, Growth Inhibition Test No 201. Available at: http://www.oecd.org/chemicalsafety/testing/1946914.pdf
 Statista. 2021. Revenue of the worldwide pharmaceutical market from 2001 to 2020. Available at: https://www.statista.com/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001/
 U.S. News & World Report. 2013. Antihistamines Adding to Drug Pollution in Streams. Available at: https://health.usnews.com/health-news/news/articles/2013/04/02/antihistamines-adding-to-drug-pollution-in-streams
 UNECE. 2017. Targets to the Protocol on Water and Health to the Convention on the Protection and Use of Transboundary Watercourses and International Lakes.
 World Health Organization. 2012. Pharmaceuticals in drinking water. Geneva: World Health Organization.
The Copyright Transfer Form to ASERS Publishing (The Publisher)
This form refers to the manuscript, which an author(s) was accepted for publication and was signed by all the authors.
The undersigned Author(s) of the above-mentioned Paper here transfer any and all copyright-rights in and to The Paper to The Publisher. The Author(s) warrants that The Paper is based on their original work and that the undersigned has the power and authority to make and execute this assignment. It is the author's responsibility to obtain written permission to quote material that has been previously published in any form. The Publisher recognizes the retained rights noted below and grants to the above authors and employers for whom the work performed royalty-free permission to reuse their materials below. Authors may reuse all or portions of the above Paper in other works, excepting the publication of the paper in the same form. Authors may reproduce or authorize others to reproduce the above Paper for the Author's personal use or for internal company use, provided that the source and The Publisher copyright notice are mentioned, that the copies are not used in any way that implies The Publisher endorsement of a product or service of an employer, and that the copies are not offered for sale as such. Authors are permitted to grant third party requests for reprinting, republishing or other types of reuse. The Authors may make limited distribution of all or portions of the above Paper prior to publication if they inform The Publisher of the nature and extent of such limited distribution prior there to. Authors retain all proprietary rights in any process, procedure, or article of manufacture described in The Paper. This agreement becomes null and void if and only if the above paper is not accepted and published by The Publisher, or is with drawn by the author(s) before acceptance by the Publisher.